Scotts Miracle-Gro Q2 GAAP EPS $3.72; adjusted EBITDA $402.8M, reaffirms guidance

SCOTTS MIRACLE-GRO CO

2025-Q2 EPS reported $2.53 revenue$1,837,800,000

Q2 GAAP EPS $3.72 vs $2.74 prior year; adjusted EPS $3.98 vs $3.69.
Total sales $1.42B down 7% YoY; U.S. Consumer sales down 5% to $1.31B.
GAAP gross margin 38.6% (up 820bps); adjusted gross margin 39.1% (up 380bps).
Adjusted EBITDA $402.8M vs $396.3M; net leverage improved to 4.41x from 6.95x.
Reaffirms full-year guidance for U.S. Consumer, but drops Hawthorne revenue guidance due to cannabis uncertainty.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.